Brian C Capell, M.D., Ph.D.

faculty photo
Assistant Professor of Dermatology
Medical Staff, Attending Physician, Hospital of the University of Pennsylvania, Department of Dermatology, Philadelphia, PA
Medical Staff, Active Member, Presbyterian Medical Center, Department of Dermatology, Philadelphia, PA
Medical Staff, Attending Physician, Pennsylvania Hospital, Department of Dermatology, Philadelphia, PA
Co-Director, Cutaneous Phenomics and Transcriptomics Core, Penn Skin Biology and Diseases Resource-based Center (SBDRC)
Department: Dermatology

Contact information
Biomedical Research Building
Office: 1007
Lab: 1020-21
Philadelphia, PA 19104
Office: 215- 746-8225
BS (Biology)
Boston College, 2000.
PhD (Cellular and Molecular Biology)
New York University, 2008.
New York University School of Medicine, 2009.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Squamous cell carcinoma and actinic keratoses, basal cell carcinoma, melanoma

Description of Research Expertise

The Capell Lab seeks to answer fundamental questions regarding how epigenetic processes (histone, RNA, DNA) are impacted by intrinsic (i.e. aging, sex chromosomes) and extrinsic (i.e. ultraviolet radiation, diet, etc.) environmental influences, and how these changes impact cellular homeostasis (i.e. metabolism, immunity) to promote epithelial diseases such as cancer.

By combining innovative in vivo models and human patient samples with the most cutting-edge epigenetic approaches, we aim to identify therapeutic vulnerabilities and novel targets to treat disease.

Epigenetics, epitranscriptomics, transcriptional regulation, cancer, aging, epithelial and cutaneous biology, ferroptosis and lipid metabolism

Epithelial tissues rely on a highly coordinated balance between self-renewal, proliferation, and differentiation. Epigenetic mechanisms provide this precise control through the regulation of gene expression in order to establish and maintain cell fate and identity. Disruption of these pathways can disrupt diverse cellular processes including both metabolism and immunity, and ultimately drive diseases such as cancer.

Consistent with this, chromatin modifiers and modifications are commonly dysregulated in diseases ranging from developmental disorders to age-related diseases such as cancer. For example, there is an exceptionally high incidence of mutations in epigenetic modifiers in cancers of self-renewing epithelial tissues such as squamous cell carcinoma (SCC). SCC is the most common type of cancer worldwide, affecting numerous epithelial tissues ranging from the skin and eyes to the lung, esophagus, and oropharynx. Despite this, precisely how disruption of epigenetic homeostasis may drive epithelial cancers such as SCC is poorly understood.

In the Capell Lab, we combine cutting-edge epigenetic technologies, human patient samples, primary cells, and mouse models in order to solve fundamental unanswered questions:

- How are epigenetic processes (histone, RNA, DNA) impacted by intrinsic (i.e. aging, sex chromosomes) and extrinsic (i.e. ultraviolet radiation, diet, etc.) environmental influences, and how do these changes impact cellular homeostasis (i.e. metabolism, immunity) to promote epithelial diseases such as cancer?

- By elucidating these mechanisms, can we identify new targets and therapeutic vulnerabilities for the prevention and treatment of these potentially deadly conditions?

If you would be interested in joining our team, please contact us!

If you would be interested in discussing potential rotation projects, please contact us (

Brian Capell, MD, PhD
Lydia Bao
Chase Chen
Carina D'souza
Eni Harito
Sijia Huang, PhD
Eun Kyung Ko, PhD
Nina Kuprasertkul
Alyssa Moore
Gina Pacella

Selected Publications

Egolf S, Zou J, Anderson A, Simpson CL, Aubert Y, Prouty S, Ge K, Seykora JT, Capell BC: MLL4 mediates differentiation and tumor suppression through ferroptosis. Sci Adv 7(50): eabj9141, Dec 2021 Notes: Epub 2021 Dec 10 ; doi: 10.1126/sciadv.abj9141.

Huang S, Kuri P, Aubert Y, Brewster M, Li N, Farrelly O, Rice G, Bae H, Prouty S, Dentchev T, Luo W, Capell BC, Rompolas P.: Lgr6 marks epidermal stem cells with a nerve-dependent role in wound re-epithelialization. Cell Stem Cell ell Stem Cell: 1582-1596, Sep 2021.

Pacella G, Capell BC.: Epigenetic and metabolic interplay in cutaneous squamous cell carcinoma. Exp Dermatol 30(8): 1115-1125, Aug 2021 Notes: doi: 10.1111/exd.14354. Epub 2021 Apr 22.

Ko EK, Capell BC.: Methyltransferases in the Pathogenesis of Keratinocyte Cancers. Cancers (Basel) 13: 3402, Jul 2021.

Maldonado López A, Capell BC.: The METTL3-m(6)A Epitranscriptome: Dynamic Regulator of Epithelial Development, Differentiation, and Cancer. Genes (Basel) 12: 1019, Jun 2021.

Zheng Q, Capell BC, Parekh V, O'Day C, Atillasoy C, Bashir HM, Yeh C, Shim EH, Prouty SM, Dentchev T, Lee V, Wushanley L, Kweon Y, Suzuki-Horiuchi Y, Pear W, Grice EA, Seykora JT.: Whole-Exome and Transcriptome Analysis of UV-Exposed Epidermis and Carcinoma In Situ Reveals Early Drivers of Carcinogenesis. J Invest Dermatol 141: 295-307, Feb 2021.

Egolf S, Capell BC: LSD1: a viable therapeutic target in cutaneous squamous cell carcinoma? Expert opin ther targets 24(7): 671-678, Jul 2020.

Aubert Yann, Egolf Shaun, Capell Brian C: The Unexpected Noncatalytic Roles of Histone Modifiers in Development and Disease. Trends in genetics : TIG 35(9): 645-657, Sep 2019.

Egolf Shaun, Aubert Yann, Doepner Miriam, Anderson Amy, Maldonado-Lopez Alexandra, Pacella Gina, Lee Jessica, Ko Eun Kyung, Zou Jonathan, Lan Yemin, Simpson Cory L, Ridky Todd, Capell Brian C: LSD1 Inhibition Promotes Epithelial Differentiation through Derepression of Fate-Determining Transcription Factors. Cell reports 28(8): 1981-1992.e7, Aug 2019.

Lin-Shiao Enrique, Lan Yemin, Coradin Mariel, Anderson Amy, Donahue Greg, Simpson Cory L, Sen Payel, Saffie Rizwan, Busino Luca, Garcia Benjamin A, Berger Shelley L, Capell Brian C: KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis. Genes & development 32(2): 181-193, Jan 2018.

back to top
Last updated: 07/16/2024
The Trustees of the University of Pennsylvania